[Trial of Idarac in stomatology and maxillofacial surgery (author's transl)].
In the light of a study involving a group of 50 patients hospitalised or seen on an ambulatory basis in a department of Stomatology and Maxillofacial surgery, Idarac (floctafenine) was felt to be an effective analgesic, at an average dose of 4 tablets. Tolerance was excellent from a clinical standpoint, rendering the drug easy to use, both on an out-patient basis as well as postoperatively.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy*; D014076:Tooth Diseases / Q000188:drug therapy*; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000700:Analgesics; D062367:ortho-Aminobenzoates
Essai de i'Idarac en stomatologie et chirurgie maxillo-faciale.